CN112553221B - Bifunctional thiolase gene MvaE, expression vector, recombinant strain and application thereof - Google Patents

Bifunctional thiolase gene MvaE, expression vector, recombinant strain and application thereof Download PDF

Info

Publication number
CN112553221B
CN112553221B CN202011258653.1A CN202011258653A CN112553221B CN 112553221 B CN112553221 B CN 112553221B CN 202011258653 A CN202011258653 A CN 202011258653A CN 112553221 B CN112553221 B CN 112553221B
Authority
CN
China
Prior art keywords
ala
bifunctional
mvae
thiolase
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011258653.1A
Other languages
Chinese (zh)
Other versions
CN112553221A (en
Inventor
周佳
田宝霞
李相前
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yangzhou Mataris Biotechnology Co ltd
Original Assignee
Huaiyin Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huaiyin Institute of Technology filed Critical Huaiyin Institute of Technology
Priority to CN202011258653.1A priority Critical patent/CN112553221B/en
Publication of CN112553221A publication Critical patent/CN112553221A/en
Application granted granted Critical
Publication of CN112553221B publication Critical patent/CN112553221B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01034—Hydroxymethylglutaryl-CoA reductase (NADPH) (1.1.1.34)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a bifunctional thiolase geneMvaE. The invention also discloses a bifunctional thiolase, an expression cassette, a recombinant vector, a recombinant bacterium or cell and application thereof. The invention also discloses a method for producing fatty acid. The difunctional thiolase gene MvaE can utilize rich culture medium containing glucose, glycerol or other carbon sources as raw materials under the facultative anaerobic condition, so that the C content in host bacteria can be remarkably increased 14:0 ，C 16:0 And C 18:0 The fatty acid content, the magnitude of increase varies from 27% to 213% depending on the host strain.

Description

Bifunctional thiolase gene MvaE, expression vector, recombinant strain and application thereof
Technical Field
The invention belongs to the technical field of biology, and particularly relates to a bifunctional thiolase gene MvaE, an expression vector, a recombinant strain and application thereof.
Background
Fatty acids are important platform chemicals that can be widely used in the synthesis of biofuels, organic detergents, rubber compounds, plastic products, textile chemicals, and food additives. The traditional fatty acid acquisition routes include direct extraction and separation from animal and plant cells and chemical synthesis from petroleum products. The methods have the defects of low efficiency, high cost, high land occupancy rate, unfriendly environment and the like. Compared with the conventional method, the microbial synthesis method of fatty acid has inherent advantages in cost, land occupancy rate and environmental protection, and is considered to be the most potential method capable of replacing the conventional method. However, the key technology which restricts the microbial synthesis efficiency of fatty acid is not completely solved. The yield and the type of the microbial synthesized fatty acid are closely related to the optimization of a fatty acid metabolic pathway and the catalytic property of key enzyme.
Biosynthesis of fatty acids is achieved primarily by two metabolic pathways, namely through the forward synthesis of fatty acids and the reverse cycle of fatty acid beta-oxidation. Some thiolases can promote a reverse cycle of beta-oxidation of fatty acids, causing the product of beta-oxidation of fatty acids, acetyl-coa, to flow back along the beta-oxidation pathway of fatty acids in a reverse direction to fatty acid formation. Studies have shown that different types of thiolases can affect the efficiency of fatty acid synthesis and the extension length of the carbon chain. Endogenous thiolase, dehydrogenase and a series of exogenous thioesterases are co-expressed in escherichia coli, so that reverse cycle synthesis of fatty acid and fatty alcohol with different chain lengths can be promoted by fatty acid beta-oxidation, and short-chain enrichment is realized. The synthesized thiolase and the fatty acid synthetase in the forward path are co-expressed to enhance the reduction reaction in the beta-oxidation reverse cycle and accelerate the synthesis of fatty acid. The yield of fatty acid is influenced by various factors, wherein the selection of key enzyme and the synergistic expression of various fatty acid metabolism related genes play an important role in improving the synthesis efficiency of fatty acid and regulating the length of a carbon chain synthesized by fatty acid.
Disclosure of Invention
The invention aims to: in order to solve the defects of the prior art, the invention provides the bifunctional thiolase gene MvaE.
The technical problem to be solved by the invention is to provide the bifunctional thiolase.
The invention also aims to solve the technical problem of providing an expression cassette, a recombinant vector, a recombinant bacterium or a cell, which contains the bifunctional thiolase gene MvaE.
The invention also aims to solve the technical problem of providing the application of the bifunctional thiolase gene MvaE, the bifunctional thiolase, the expression cassette, the recombinant vector, the recombinant bacterium or the cell in fatty acid synthesis.
The invention finally solves the technical problem of providing a method for producing fatty acid.
The technical scheme is as follows: in order to solve the technical problems, the invention provides a bifunctional thiolase gene MvaE, wherein the nucleotide sequence of the bifunctional thiolase gene MvaE is as follows:
i) The amino acid sequence of SEQ ID NO:1 or the nucleotide sequence shown in SEQ ID NO: 2; or
ii) SEQ ID NO:1 or SEQ ID NO:2 is substituted, deleted and/or added with one or more nucleotides and has the same function; or
iii) A nucleotide sequence having 90% or more homology with the nucleotide sequence of i) and ii) and having the same function.
The invention also comprises a bifunctional thiolase, the amino acid sequence of which is shown in SEQ ID NO:3, respectively.
The invention also comprises an expression cassette, a recombinant vector, a recombinant bacterium or a cell, which contains the bifunctional thiolase gene MvaE.
Wherein the recombinant vector is obtained by introducing the bifunctional thiolase gene MvaE into a vector plasmid pSTV 28.
The recombinant strain is a recombinant strain containing expressible MvaE, wherein the recombinant strain is obtained by introducing the bifunctional thiolase gene MvaE into host bacteria, and screening and identifying the host bacteria and then retaining a positive strain.
Wherein, the host bacteria include but are not limited to Escherichia coli MG1655.
The invention also comprises the application of the bifunctional thiolase gene MvaE, the bifunctional thiolase, the expression cassette, the recombinant vector, the recombinant bacterium or the cell in fatty acid synthesis.
The invention also discloses a method for producing fatty acid, which is obtained by inoculating the recombinant bacterium into a fermentation culture medium for fermentation culture.
Wherein the fermentation temperature is 25-38 ℃; the initial pH value of the fermentation system is 6.5-7.5; the carbon source in the fermentation medium is one or more of glycerol, glucose and starch; the nitrogen source in the fermentation medium is one or more of yeast powder, peptone, ammonia water, ammonium salt and urea.
Wherein the fermentation medium comprises glycerol, peptone, yeast powder and sodium chloride, and is dissolved in MOPS buffer solution with pH of 7.0-7.5.
The recombinant strain can over-express the difunctional thiolase gene MvaE,thereby remarkably improving C in host bacteria 14：0 ，C 16：0 And C 18：0 Fatty acid content.
Has the advantages that: compared with the prior art, the invention has the following advantages: the over-expressed artificially designed bifunctional thiolase gene MvaE can utilize rich culture medium containing glucose, glycerol or other carbon sources as raw materials under the condition of facultative anaerobism, and can remarkably improve C content in host bacteria 14：0 ，C 16：0 And C 18：0 The fatty acid content, the increase range of which varies from 27% to 213% depending on the host strain.
Drawings
FIG. 1 is a graph of the effect of MvaE on the colony morphology of E.coli MG 1655;
FIG. 2 is an Anthony capsular staining experiment;
FIG. 3 shows Sudan black staining experiment.
Detailed Description
Embodiments of the present invention will be described in detail below with reference to examples using Escherichia coli as a host bacterium, but those skilled in the art will appreciate that the following examples are only illustrative of the present invention and should not be construed as limiting the scope of the present invention. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products commercially available.
Example 1: artificial design and synthesis of bifunctional thiolase gene MvaE based on codon preference of escherichia coli
According to SEQ ID NO:1 the MvaE gene codon is optimized to facilitate its expression in E.coli. The optimized nucleic acid sequence is shown as SEQ NO:2, respectively. The gene sequence after codon optimization is synthesized by the company Limited in the Biotechnology engineering (Shanghai), and the 5 'end and the 3' end of the synthesized gene sequence are respectively provided with BamH I restriction enzyme cutting sites and Hind III restriction enzyme cutting sites.
Example 2: construction of expression vector pSTmvAE for expression of MvaE Gene in Large intestine rods
The peptide has the sequence shown in SEQ NO:2 on an expression vector, such as the pSTV28 vector. The specific implementation steps are as follows:
the synthetic DNA fragment of example 1 and the vector plasmid pSTV28 were double digested with BamH I and Hind III, respectively; and (3) recovering the enzyme-cut DNA fragment and the large vector fragment by agarose electrophoresis, and connecting the enzyme-cut gene fragment to a corresponding enzyme-cut product of pSTV28 at 16 ℃ sequentially by using DNA ligase to form pSTmvAE. Each ligation product was used to transform E.coli MG1655, which was plated on a petri dish containing 30. Mu.g/mL of Cmp (chloramphenicol) and incubated at 37 ℃ for 10-12h. And selecting a single colony on the next day, and extracting plasmids by using a Shanghai biological medium particle small quantity extraction kit. And carrying out double enzyme digestion verification on the obtained plasmid and sequencing the obtained recombinant plasmid. The results show that the pSTmvAE plasmid was successfully constructed.
Example 3 construction of recombinant Escherichia coli overexpressing bifunctional thiolase Gene MvaE
The pSTV28 and pSTmvae plasmids in example 2 were respectively transformed into Escherichia coli MG1655 to respectively obtain engineered Escherichia coli MG: pSTV28 and pSMG: pSTmvae.
Example 4: fermentation culture of recombinant Escherichia coli
The engineered strain MG obtained in example 3: pSTV28 and pSMG: positive single colonies of pSTmvae were inoculated into 5mL LB tubes containing 30. Mu.g/mL chloramphenicol for 8 hours at 37 ℃ and 50mL of fermentation medium containing 30. Mu.g/mL chloramphenicol at an inoculum size of 1% (v/v).
Fermentation medium formula (1L): 2g glycerol, 10g peptone, 10g yeast powder and 5g sodium chloride were dissolved in 800ml 10mM MOPS buffer, pH7.0-7.5 and finally made up to 1000ml with 10mM MOPS.
And (3) inoculating the engineering bacteria MG of the escherichia coli in a shaker at 30 ℃ and 250 rpm: pSTV28 and pSMG: fermentation of pSTmvae culture to OD 600 Isopropyl beta-D-thiogalactoside (IPTG) was added at 0.4-0.6 to a final concentration of 0.1mM as an inducer and incubated under these conditions for 24 hours for sampling for subsequent cell concentration and fatty acid component detection (see example 5 for the results of specific fatty acid component detection).
Example 5: effect of overexpression of MvaE on colony morphology of Escherichia coli MG1655 and enrichment of neutral oil
The colony morphology of the escherichia coli recombinant expression strain of the bifunctional thiolase MvaE is remarkably changed compared with that of a control group which does not express the enzyme, and the colony morphology is in an oil drop shape or a viscous liquid shape (figure 1A) to show a sample application result; fig. 1B shows the scribing result.
An Anthony capsular staining experiment was performed on the MvaE recombinant expression strain and the control group (fig. 2). The specific experimental steps are as follows: a negative dyeing method: (1) tabletting: taking a clean glass slide, adding a drop of distilled water, taking a small amount of thalli, putting the thalli into the drop of distilled water, uniformly mixing and coating; and (2) drying: drying the smear in air or blowing dry with cold air; (3) dyeing: adding red dye solution on the coated surface for dyeing for 2-3min; (4) washing with water: washing with water to remove red dye liquor; (5) drying: drying the dyed piece by air or blowing by electric blowing cold air; (6) melanin coating: adding a small drop of melanin on the left side of the dyeing coating surface, lightly contacting the melanin with a slide glass with a smooth edge to disperse the melanin along the edge of the slide glass, dragging the melanin to the right to form a thin layer on the dyeing coating surface, and quickly drying the melanin in the air; (7) microscopic examination: observing with a low power lens and then with a high power lens.
The results show that no capsule formation was found, thus excluding the possibility that oiling or sliming of the colonies was caused by capsule formation.
And measuring the content of neutral lipid in the saccharomyces cerevisiae by taking the sudan black B as a coloring agent. The yeast cells after induction are prepared in 70% ethanol for 10min by using 0.1% Sudan black B solution, and then are washed for more than 3 times by using the 70% ethanol to prepare a sample slide for microscopic detection. Results of sudan black B staining, a liposoluble dye, showed that the intracellular concentration of sudan black in the MvaE recombinant expression strain was significantly greater than that in the control group (fig. 3).
Example 6: c of E.coli MG1655 by overexpression of MvaE 14：0 、C 16：0 And C 18：0 Gas chromatography detection of fatty acid content
The extraction and esterification method of the fatty acid of the escherichia coli comprises the following steps:
(1) Taking 4mL of the liquid fermentation liquid obtained by the fermentation method of the embodiment 4, centrifuging at 8000 rpm for 15min, removing the supernatant, adding 1mL of deionized water for resuspension, adding 100 μ L of acetic acid for acidification, (using a 15mL plastic tube);
(2) 3mL of chloroform-methanol (1: 1 by volume) was lysed and mixed well with shaking every 10 minutes at room temperature for 2 hours.
Standing for 2 hours at room temperature;
(3) 0.5mL of the lower organic phase was placed in a fresh 1.5mL centrifuge tube with a lid and vacuum dried (longer time, overnight);
(4) The dried organic phase was resuspended in 300. Mu.L of 5% sulfuric acid/methanol (5% sulfuric acid in methanol; vol/vol) solution. The containers were used as 1.5ml centrifuge tubes with lids. Carrying out warm bath at 60 ℃ for 4h (60 ℃ oven);
(5) Adding 300 mu L of 0.9% (wt/vol) NaCl solution into the reaction mixed solution, shaking and uniformly mixing;
(6) Extracting fatty acid methyl ester with 600 μ L of dichloromethane (shaking and mixing every 10 minutes, room temperature 1 hr);
(7) Transferring the lower dichloromethane layer of 300-400 mu L to a gas chromatography glass bottle for gas chromatography detection.
The operation method of the gas chromatograph comprises the following steps: (1) And (3) temperature programming, setting the initial temperature to be 40 ℃, the retention time to be 3min, heating to 120 ℃ at the speed of 10 ℃/min, heating to 230 ℃ at the speed of 20 ℃/min, and the retention time to be 2min. (2) Then setting the temperature of a sample inlet to be 250 ℃, the temperature of an FID detector to be 280 ℃, the sample injection volume to be 0.2 mu L and the split ratio to be 25: 1, after setting, putting the gas chromatographic columns in the gas chromatograph in sequence, and clicking start to start operation.
The gas chromatography detection result shows that C 14：0 ，C 16：0 And C 18：0 Total fatty acid content was 78% higher than that of the empty plasmid control group (Table 1), further confirming that MvaE overexpresses C in E.coli 14：0 ，C 16：0 And C 18：0 The fatty acid content is increased to various degrees.
TABLE 1 gas chromatographic determination of the intracellular content of the three major fatty acids of E.coli a
Figure BDA0002772893420000061
a. Each strain was cultured in LB liquid medium without induction by an inducer (using leaky expression) for 24 hours.
b. A fatty acid.
c. Strain MG: pSTmvae to MG: increase in the fatty acid content of pSTV 28.
d. The increase rate of the fatty acid content; (Δ FA/MG: pSTV 28) 100.
e. Here the total amount of fatty acids is represented by C 14：0 ，C 16：0 And C 18：0 Sum of fatty acid content.
Sequence listing
<110> Huaiyin institute of Industrial and technology
<120> bifunctional thiolase gene MvaE, expression vector, recombinant strain and application thereof
<160> 3
<170> SIPOSequenceListing 1.0
<210> 1
<211> 2436
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
atgaaaaatt gtgtcatcgt cagtgcggta cgtactgcta tcggtagttt taacggttca 60
ctcgcttcca ccagcgccat cgacctgggg gcgacagtaa ttaaagccgc cattgaacgt 120
gcaaaaatcg attcacaaca cgttgatgaa gtgattatgg gtaacgtgtt acaagccggg 180
ctggggcaaa atccggcgcg tcaggcactg ttaaaaagcg ggctggcaga aacggtgtgc 240
ggattcacgg tcaataaagt atgtggttcg ggtcttaaaa gtgtggcgct tgccgcccag 300
gccattcagg caggtcaggc gcagagcatt gtggcggggg gtatggaaaa tatgagttta 360
gccccctact tactcgatgc aaaagcacgc tctggttatc gtcttggaga cggacaggtt 420
tatgacgtaa tcctgcgcga tggcctgatg tgcgccaccc atggttatca tatggggatt 480
accgccgaaa acgtggctaa agagtacgga attacccgtg aaatgcagga tgaactggcg 540
ctacattcac agcgtaaagc ggcagccgca attgagtccg gtgcttttac agccgaaatc 600
gtcccggtaa atgttgtcac tcgaaagaaa accttcgtct tcagtcaaga cgaattcccg 660
aaagcgaatt caacggctga agcgttaggt gcattgcgcc cggccttcga taaagcagga 720
acagtcaccg ctgggaacgc gtctggtatt aacgacggtg ctgccgctct ggtgattatg 780
gaagaatctg cggcgctggc agcaggcctt acccccctgg ctcgcattaa aagttatgcc 840
agcggtggcg tgccccccgc attgatgggt atggggccag tacctgccac gcaaaaagcg 900
ttacaactgg cggggctgca actggcggat attgatctca ttgaggctaa tgaagcattt 960
gctgcacagt tccttgccgt tgggaaaaac ctgggctttg attctgagaa agtgaatgtc 1020
aacggcgggg ccatcgcgct cgggcatcct atcggtgcca gtggtgctcg tattctggtc 1080
acactattac atgccatgca ggcacgcgat aaaacgctgg ggctggcaac actgtgcatt 1140
ggcggcggtc agggaattgc gatggtgatt gaacggttga atggaggcgg tggttcgggt 1200
ggtggtggta gcatgagtcc tgacgaacgc ctgggatctc ttctccaaga aggccagatt 1260
tctgctgata caaaaaaaga atttgaaaat acggctttat cttcgcagat tgccaatcat 1320
atgattgaaa atcaaatcag tgaaacagaa gtgccgatgg gcgttggctt acatttaaca 1380
gtggacgaaa ctgagtattt ggtaccaatg gcgacagaag agccctcagt gattgcggct 1440
ttgagtcaag gtgggcatct ggcaaatgga tttaaaacag tgaatcaaca acgtttaatg 1500
cgtggacaac tggtttttta cgatgttgca gacgccgagt cattgattga tgaactacaa 1560
gtacgtgaat tcgaaatttt tcaacaagca gagttaagtt atccatctat cgttaaacgc 1620
ggcggcggct taagagattt gcaatatcgt gcttttgatg aatcacgcgt atctgtcgac 1680
tttttagtag atgttaagga tgcaatgggg gcaaatatcg ttaacgctat gttggaaggt 1740
gtggccgagt atctccgtga atggtttgcg gagcaaaaga ttttattcag tattttaagt 1800
aattatgcca cggagtcggt tgttacgatg aaaacggcta ttccagtttc acgtttaagt 1860
aaggggagca atggccggga aattgctgaa aaaattgttt tagcttcacg ctatgcttca 1920
ttagatcctt atcgggcagt cacgcataac aaagggatca tgaatggcat tgaagctgtc 1980
gttttagcta caggaaatga tacacgcgct gttagcgctt cttgtcatgc ttttgcggtg 2040
aaggaagatc gctaccaagg tttgactagt tggaatctgg atggcgaaca actaattggt 2100
gaaatttcag ttccgcttgc gttagccacg gttggcggtg ccacaaaagt cttacctaaa 2160
tctcaagcag ctgctgattt gttagcagtg acggatgcaa aagaactaag tcgagtagta 2220
gcggctgttg gtttggcaca aaatttagcg gcgttacggg ccttagtctc tgaaggaatt 2280
caaaaaggac acatggctct acaagcacat ccaatagcga tgacggtcgg agctactggt 2340
aaagaagttg aggcagtcgc tcaacaatta aaacgtcaaa aaacgatgaa ccaagaccga 2400
gccttggcta ttttaaatga tttaagaaaa caataa 2436
<210> 2
<211> 2469
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
ttggatccag gaggtaataa atatgaaaaa ttgtgtcatc gtcagtgcgg tacgtactgc 60
tatcggtagt tttaacggtt cactcgcttc caccagcgcc atcgacctgg gggcgacagt 120
aattaaagcc gccattgaac gtgcaaaaat cgattcacaa cacgttgatg aagtgattat 180
gggtaacgtg ttacaagccg ggctggggca aaatccggcg cgtcaggcac tgttaaaaag 240
cgggctggca gaaacggtgt gcggattcac ggtcaataaa gtatgtggtt cgggtcttaa 300
aagtgtggcg cttgccgccc aggccattca ggcaggtcag gcgcagagca ttgtggcggg 360
gggtatggaa aatatgagtt tagcccccta cttactcgat gcaaaagcac gctctggtta 420
tcgtcttgga gacggacagg tttatgacgt aatcctgcgc gatggcctga tgtgcgccac 480
ccatggttat catatgggga ttaccgccga aaacgtggct aaagagtacg gaattacccg 540
tgaaatgcag gatgaactgg cgctgcattc acagcgtaaa gcggcagccg caattgagtc 600
cggtgctttt acagccgaaa tcgtcccggt aaatgttgtc actcgtaaga aaaccttcgt 660
cttcagtcaa gacgaattcc cgaaagcgaa ttcaacggct gaagcgttag gtgcattgcg 720
cccggccttc gataaagcag gaacagtcac cgctgggaac gcgtctggta ttaacgacgg 780
tgctgccgct ctggtgatta tggaagaatc tgcggcgctg gcagcaggcc ttacccccct 840
ggctcgcatt aaaagttatg ccagcggtgg cgtgcccccc gcattgatgg gtatggggcc 900
agtacctgcc acgcaaaaag cgttacaact ggcggggctg caactggcgg atattgatct 960
cattgaggct aatgaagcat ttgctgcaca gttccttgcc gttgggaaaa acctgggctt 1020
tgattctgag aaagtgaatg tcaacggcgg ggccatcgcg ctcgggcatc ctatcggtgc 1080
cagtggtgct cgtattctgg tcacactgtt acatgccatg caggcacgcg ataaaacgct 1140
ggggctggca acactgtgca ttggcggcgg tcagggaatt gcgatggtga ttgaacggtt 1200
gaatggaggc ggtggttcgg gtggtggtgg tagcatgagt cctgacgaac gcctgggatc 1260
tcttctccaa gaaggccaga tttctgctga tacaaaaaaa gaatttgaaa atacggcttt 1320
atcttcgcag attgccaatc atatgattga aaatcaaatc agtgaaacag aagtgccgat 1380
gggcgttggc ttacatttaa cagtggacga aactgagtat ttggtaccaa tggcgacaga 1440
agagccctca gtgattgcgg ctttgagtca aggtgggcat ctggcaaatg gatttaaaac 1500
agtgaatcaa caacgtttaa tgcgtggaca actggttttt tacgatgttg cagacgccga 1560
gtcattgatt gatgaactgc aagtaagaga attcgaaatt tttcaacaag cagagttaag 1620
ttatccatct atcgttaaac gcggcggcgg cttacgtgat ttgcaatatc gtgcttttga 1680
tgaatcacgc gtatctgtcg actttttagt agatgttaag gatgcaatgg gggcaaatat 1740
cgttaacgct atgttggaag gtgtggccga gtatctccgt gaatggtttg cggagcaaaa 1800
gattttattc agtattttaa gtaattatgc cacggagtcg gttgttacga tgaaaacggc 1860
tattccagtt tcacgtttaa gtaaggggag caatggccgg gaaattgctg aaaaaattgt 1920
tttagcttca cgctatgctt cattagatcc ttatcgggca gtcacgcata acaaagggat 1980
catgaatggc attgaagctg tcgttttagc tacaggaaat gatacacgcg ctgttagcgc 2040
ttcttgtcat gcttttgcgg tgaaggaaga tcgctaccaa ggtttgacta gttggaatct 2100
ggatggcgaa caactgattg gtgaaatttc agttccgctt gcgttagcca cggttggcgg 2160
tgccacaaaa gtcttaccta aatctcaagc agctgctgat ttgttagcag tgacggatgc 2220
aaaagaactg agtcgtgtag tagcggctgt tggtttggca caaaatttag cggcgttacg 2280
ggccttagtc tctgaaggaa ttcaaaaagg acacatggct ctgcaagcac atccaatagc 2340
gatgacggtc ggagctactg gtaaagaagt tgaggcagtc gctcaacaat taaaacgtca 2400
aaaaacgatg aaccaagacc gtgccttggc tattttaaat gatttacgta aacaataatt 2460
aattaatat 2469
<210> 3
<211> 811
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 3
Met Lys Asn Cys Val Ile Val Ser Ala Val Arg Thr Ala Ile Gly Ser
1 5 10 15
Phe Asn Gly Ser Leu Ala Ser Thr Ser Ala Ile Asp Leu Gly Ala Thr
20 25 30
Val Ile Lys Ala Ala Ile Glu Arg Ala Lys Ile Asp Ser Gln His Val
35 40 45
Asp Glu Val Ile Met Gly Asn Val Leu Gln Ala Gly Leu Gly Gln Asn
50 55 60
Pro Ala Arg Gln Ala Leu Leu Lys Ser Gly Leu Ala Glu Thr Val Cys
65 70 75 80
Gly Phe Thr Val Asn Lys Val Cys Gly Ser Gly Leu Lys Ser Val Ala
85 90 95
Leu Ala Ala Gln Ala Ile Gln Ala Gly Gln Ala Gln Ser Ile Val Ala
100 105 110
Gly Gly Met Glu Asn Met Ser Leu Ala Pro Tyr Leu Leu Asp Ala Lys
115 120 125
Ala Arg Ser Gly Tyr Arg Leu Gly Asp Gly Gln Val Tyr Asp Val Ile
130 135 140
Leu Arg Asp Gly Leu Met Cys Ala Thr His Gly Tyr His Met Gly Ile
145 150 155 160
Thr Ala Glu Asn Val Ala Lys Glu Tyr Gly Ile Thr Arg Glu Met Gln
165 170 175
Asp Glu Leu Ala Leu His Ser Gln Arg Lys Ala Ala Ala Ala Ile Glu
180 185 190
Ser Gly Ala Phe Thr Ala Glu Ile Val Pro Val Asn Val Val Thr Arg
195 200 205
Lys Lys Thr Phe Val Phe Ser Gln Asp Glu Phe Pro Lys Ala Asn Ser
210 215 220
Thr Ala Glu Ala Leu Gly Ala Leu Arg Pro Ala Phe Asp Lys Ala Gly
225 230 235 240
Thr Val Thr Ala Gly Asn Ala Ser Gly Ile Asn Asp Gly Ala Ala Ala
245 250 255
Leu Val Ile Met Glu Glu Ser Ala Ala Leu Ala Ala Gly Leu Thr Pro
260 265 270
Leu Ala Arg Ile Lys Ser Tyr Ala Ser Gly Gly Val Pro Pro Ala Leu
275 280 285
Met Gly Met Gly Pro Val Pro Ala Thr Gln Lys Ala Leu Gln Leu Ala
290 295 300
Gly Leu Gln Leu Ala Asp Ile Asp Leu Ile Glu Ala Asn Glu Ala Phe
305 310 315 320
Ala Ala Gln Phe Leu Ala Val Gly Lys Asn Leu Gly Phe Asp Ser Glu
325 330 335
Lys Val Asn Val Asn Gly Gly Ala Ile Ala Leu Gly His Pro Ile Gly
340 345 350
Ala Ser Gly Ala Arg Ile Leu Val Thr Leu Leu His Ala Met Gln Ala
355 360 365
Arg Asp Lys Thr Leu Gly Leu Ala Thr Leu Cys Ile Gly Gly Gly Gln
370 375 380
Gly Ile Ala Met Val Ile Glu Arg Leu Asn Gly Gly Gly Gly Ser Gly
385 390 395 400
Gly Gly Gly Ser Met Ser Pro Asp Glu Arg Leu Gly Ser Leu Leu Gln
405 410 415
Glu Gly Gln Ile Ser Ala Asp Thr Lys Lys Glu Phe Glu Asn Thr Ala
420 425 430
Leu Ser Ser Gln Ile Ala Asn His Met Ile Glu Asn Gln Ile Ser Glu
435 440 445
Thr Glu Val Pro Met Gly Val Gly Leu His Leu Thr Val Asp Glu Thr
450 455 460
Glu Tyr Leu Val Pro Met Ala Thr Glu Glu Pro Ser Val Ile Ala Ala
465 470 475 480
Leu Ser Gln Gly Gly His Leu Ala Asn Gly Phe Lys Thr Val Asn Gln
485 490 495
Gln Arg Leu Met Arg Gly Gln Leu Val Phe Tyr Asp Val Ala Asp Ala
500 505 510
Glu Ser Leu Ile Asp Glu Leu Gln Val Arg Glu Phe Glu Ile Phe Gln
515 520 525
Gln Ala Glu Leu Ser Tyr Pro Ser Ile Val Lys Arg Gly Gly Gly Leu
530 535 540
Arg Asp Leu Gln Tyr Arg Ala Phe Asp Glu Ser Arg Val Ser Val Asp
545 550 555 560
Phe Leu Val Asp Val Lys Asp Ala Met Gly Ala Asn Ile Val Asn Ala
565 570 575
Met Leu Glu Gly Val Ala Glu Tyr Leu Arg Glu Trp Phe Ala Glu Gln
580 585 590
Lys Ile Leu Phe Ser Ile Leu Ser Asn Tyr Ala Thr Glu Ser Val Val
595 600 605
Thr Met Lys Thr Ala Ile Pro Val Ser Arg Leu Ser Lys Gly Ser Asn
610 615 620
Gly Arg Glu Ile Ala Glu Lys Ile Val Leu Ala Ser Arg Tyr Ala Ser
625 630 635 640
Leu Asp Pro Tyr Arg Ala Val Thr His Asn Lys Gly Ile Met Asn Gly
645 650 655
Ile Glu Ala Val Val Leu Ala Thr Gly Asn Asp Thr Arg Ala Val Ser
660 665 670
Ala Ser Cys His Ala Phe Ala Val Lys Glu Asp Arg Tyr Gln Gly Leu
675 680 685
Thr Ser Trp Asn Leu Asp Gly Glu Gln Leu Ile Gly Glu Ile Ser Val
690 695 700
Pro Leu Ala Leu Ala Thr Val Gly Gly Ala Thr Lys Val Leu Pro Lys
705 710 715 720
Ser Gln Ala Ala Ala Asp Leu Leu Ala Val Thr Asp Ala Lys Glu Leu
725 730 735
Ser Arg Val Val Ala Ala Val Gly Leu Ala Gln Asn Leu Ala Ala Leu
740 745 750
Arg Ala Leu Val Ser Glu Gly Ile Gln Lys Gly His Met Ala Leu Gln
755 760 765
Ala His Pro Ile Ala Met Thr Val Gly Ala Thr Gly Lys Glu Val Glu
770 775 780
Ala Val Ala Gln Gln Leu Lys Arg Gln Lys Thr Met Asn Gln Asp Arg
785 790 795 800
Ala Leu Ala Ile Leu Asn Asp Leu Arg Lys Gln
805 810

Claims (9)

1. Difunctional thiolase geneMvaE，Characterized in that the bifunctional thiolase geneMvaEThe nucleotide sequence of (A) is the nucleotide sequence shown in SEQ ID NO. 1 or the nucleotide sequence shown in SEQ ID NO. 2.
2. The bifunctional thiolase is characterized in that the amino acid sequence of the bifunctional thiolase is shown as SEQ ID NO 3.
3. An expression cassette, recombinant vector or recombinant bacterium comprising the bifunctional thiolase gene of claim 1MvaE。
4. The recombinant vector according to claim 3, wherein the recombinant vector is a bifunctional thiolase geneMvaEThe vector plasmid pSTV28 was introduced.
5. The recombinant bacterium according to claim 3, wherein the recombinant bacterium is a bifunctional thiolase geneMvaEIntroducing into host bacteria, screening and identifying, and retaining positive strain as expressible strainMvaEThe recombinant strain of (1).
6. The recombinant bacterium according to claim 5, wherein the host bacterium is Escherichia coli MG1655.
7. The bifunctional thiolase gene as claimed in claim 1MvaEThe bifunctional thiolase of claim 2, the expression cassette, the recombinant vector, or the recombinant bacterium of claim 3, for use in fatty acid synthesis.
8. A method for producing fatty acids, comprising inoculating the recombinant bacterium according to claim 5 or 6 to a fermentation medium and carrying out fermentation culture.
9. The method for producing fatty acids according to claim 8, wherein the fermentation temperature is 25-38 ℃; the initial pH value of the fermentation system is 6.5-7.5; the carbon source in the fermentation medium is one or more of glycerol, glucose and starch; the nitrogen source in the fermentation medium is one or more of yeast powder, peptone, ammonia water, ammonium salt and urea.
CN202011258653.1A 2020-11-11 2020-11-11 Bifunctional thiolase gene MvaE, expression vector, recombinant strain and application thereof Active CN112553221B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011258653.1A CN112553221B (en) 2020-11-11 2020-11-11 Bifunctional thiolase gene MvaE, expression vector, recombinant strain and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011258653.1A CN112553221B (en) 2020-11-11 2020-11-11 Bifunctional thiolase gene MvaE, expression vector, recombinant strain and application thereof

Publications (2)

Publication Number Publication Date
CN112553221A CN112553221A (en) 2021-03-26
CN112553221B true CN112553221B (en) 2023-01-31

Family

ID=75042999

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011258653.1A Active CN112553221B (en) 2020-11-11 2020-11-11 Bifunctional thiolase gene MvaE, expression vector, recombinant strain and application thereof

Country Status (1)

Country Link
CN (1) CN112553221B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114196609B (en) * 2021-12-31 2023-06-23 淮阴工学院 Escherichia coli engineering bacteria for synthesizing pure polylactic acid from lactic acid, and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110144300A (en) * 2019-05-14 2019-08-20 广东省微生物研究所（广东省微生物分析检测中心） A kind of restructuring yeast strains and its application in carotenogenesis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110144300A (en) * 2019-05-14 2019-08-20 广东省微生物研究所（广东省微生物分析检测中心） A kind of restructuring yeast strains and its application in carotenogenesis

Also Published As

Publication number Publication date
CN112553221A (en) 2021-03-26

Similar Documents

Publication Publication Date Title
CN103710374B (en) A kind of 5 amino-laevulic acid producing bacterial strains and preparation method and application
CN111548979B (en) Recombinant escherichia coli for synthesizing lactoyl N-neotetraose and construction method and application thereof
CN111690585B (en) recombinant serratia marcescens with rcsB gene deletion and application thereof
CN112553221B (en) Bifunctional thiolase gene MvaE, expression vector, recombinant strain and application thereof
CN112680433B (en) Method for producing and secreting protein by using halophilic bacteria
CN101260394A (en) Activity expression and application of thermobifida fusca xylose isomerase in wine brewing yeast
CN111349640B (en) Trans-4-hydroxy-L-proline production strain and construction method and application thereof
CN101748069A (en) recombinant blue-green algae
CN110951803A (en) Method for preparing high-purity neoagarobiose by combined utilization of specific agarase and application
CN104593407A (en) Pichia stipitis gene expression system as well as construction and application thereof
CN113564183A (en) Method for improving synthesis of prodigiosin by serratia marcescens through overexpression gene psrA
Chen et al. Ribosome-binding sequences (RBS) engineering of key genes in Escherichia coli for high production of fatty alcohols
CN106754979A (en) A kind of gene of long-chain fat acid transporter of regulation and control candida tropicalis and its application
CN112708569A (en) Yeast engineering bacterium for producing chondroitin sulfate by fermentation and application thereof
CN111718884B (en) BVG90_08615 gene-deleted serratia marcescens engineering bacterium
CN111826372B (en) Engineering strain for producing butanol by using xylose and construction method and application thereof
CN113817704A (en) Cyclodextrin glucosyltransferase with improved organic solvent tolerance and preparation method thereof
CN103060255B (en) Genetically engineering bacterium capable of producing S-3-hydroxy-butanone as well as construction method and application thereof
KR20120048638A (en) Recombinant microorganism and method for producing aliphatic polyester with the use of the same
CN102277327B (en) Colon bacillus for over-expressing RimL and application on preparing N-extrasin alpha acetylate
CN101423814B (en) Clostridium for synthesizing glutathion and construction method and use thereof
CN114752606B (en) Transcription regulator PfaR for promoting Shewanella EPA synthesis and application thereof
CN118207171B (en) Biotin ligase mutant and its use in biotin production
CN114854726B (en) Mutant of fatty acid light decarboxylase McFAP and application thereof
CN113061169B (en) Transcription regulation protein and application thereof in conjugated linoleic acid production

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20230721

Address after: Room 401, Building 25, Tongyun Trade City, No. 158, Yunhe South Road, Guangling District, Yangzhou City, Jiangsu Province, 225000

Patentee after: Yangzhou Mataris Biotechnology Co.,Ltd.

Address before: 223003 No. 1 Meizheng East Road, Huaian Higher Education Park, Jiangsu Province

Patentee before: HUAIYIN INSTITUTE OF TECHNOLOGY

TR01 Transfer of patent right